Prurigo Nodularis Treatment Market
Prurigo Nodularis Treatment Market Forecasts to 2032 – Global Analysis By Treatment Type (Topical Treatments, Systemic Treatments, Cryotherapy, Phototherapy, Pulsed Dye Laser, Intralesional Corticosteroid Injections, Medical Tape/Occlusion and Other Treatment Types), Route of Administration (Topical, Oral and Parenteral), Diagnosis Method, Type of Nodular Prurigo, Distribution Channel and By Geography
According to Stratistics MRC, the Global Prurigo Nodularis Treatment Market is accounted for $2.2 billion in 2025 and is expected to reach $3.4 billion by 2032 growing at a CAGR of 6.3% during the forecast period. Prurigo Nodularis treatment focuses on alleviating intense itching, reducing nodular lesions, and improving quality of life. Management typically involves topical therapies such as corticosteroids and anti-itch creams, systemic medications like immunomodulators or biologics (e.g., dupilumab), and phototherapy. Dermatologists tailor treatment plans based on severity and underlying conditions. Patient education on avoiding scratching and maintaining proper skin care is essential. Regular follow-ups help monitor progress and adjust therapies, aiming for long-term symptom control and skin healing.
Market Dynamics:
Driver:
Rising prevalence and increased diagnosis rates of prurigo nodularis
The increasing incidence of prurigo nodularis, particularly among individuals with chronic dermatological and systemic conditions, is a major growth driver. Enhanced awareness among healthcare providers and patients has led to earlier and more accurate diagnoses. This trend is further supported by improved access to dermatology consultations and diagnostic tools. As the disease burden grows, so does the demand for effective therapies, especially those targeting the underlying immunological mechanisms rather than just symptomatic relief.
Restraint:
High cost of advanced therapies and limited access in emerging markets
Despite promising developments in biologics and targeted treatments, the high cost of these therapies remains a significant barrier. In developing regions, limited reimbursement frameworks and uneven healthcare infrastructure restrict patient access. Additionally, gaps in physician training and awareness about newer treatment modalities further hinder adoption. These challenges collectively slow market penetration and limit the reach of innovative solutions.
Opportunity:
Increasing investment in R&D for targeted biological and small molecule therapies
Pharmaceutical companies are intensifying their focus on developing biologics and small molecule drugs that disrupt the itch-scratch cycle and modulate immune responses. Regulatory support, such as breakthrough therapy designations, is accelerating clinical trials and approvals. Strategic collaborations between industry and academia are also expanding the therapeutic pipeline. These efforts are expected to yield safer, more effective treatments and broaden the market’s scope.
Threat:
Limited reimbursement policies for novel therapies
While biologics like dupilumab and nemolizumab show strong efficacy, their adoption is constrained by restrictive reimbursement policies, especially outside North America and Western Europe. Payers remain cautious due to high costs and limited long-term data. This financial uncertainty discourages widespread use and may slow innovation. Without broader insurance coverage, many patients may continue relying on less effective conventional treatments.
Covid-19 Impact:
The pandemic had a dual impact on the prurigo nodularis treatment market. On one hand, supply chain disruptions and reduced dermatology visits temporarily slowed treatment uptake. On the other, heightened awareness of chronic conditions and the expansion of teledermatology encouraged remote consultations and continuity of care. The crisis also accelerated digital health adoption, enabling better disease monitoring and patient engagement, which ultimately supported market recovery and growth
The systemic treatments segment is expected to be the largest during the forecast period
The systemic treatments segment is expected to account for the largest market share during the forecast period due to their superior efficacy in managing severe and refractory cases. These treatments offer long-term relief by targeting inflammatory pathways, making them preferable over topical agents. The growing availability of approved biologics and ongoing clinical trials for novel agents are reinforcing this markets leadership boosting its presence.
The chronic nodular prurigo segment is expected to have the highest CAGR during the forecast period
Over the forecast period, the chronic nodular prurigo segment is predicted to witness the highest growth rate. Chronic nodular prurigo, characterized by persistent, treatment-resistant itch and nodules, demands advanced therapeutic approaches. The debilitating nature of the condition drives patients to seek long-term solutions, boosting demand for biologics and immune modulators. Increased diagnosis and awareness are further fueling the growth of the market.
Region with largest share:
During the forecast period, the Asia Pacific region is expected to hold the largest market share attributed to rising dermatological disease prevalence, expanding healthcare infrastructure, and growing access to biologic therapies. Countries like China, India, and Japan are investing in dermatology modernization and clinical research, enhancing treatment availability. Government initiatives promoting skin health and early diagnosis are also contributing to regional dominance.
Region with highest CAGR:
Over the forecast period, the North America region is anticipated to exhibit the highest CAGR driven by its advanced healthcare infrastructure and early adoption of biologic therapies. The United States leads in clinical research, with a high volume of ongoing trials for novel agents such as IL-31 and IL-4/13 inhibitors, which are reshaping the therapeutic landscape. Canada, while slightly more conservative in reimbursement policies, is expanding access through public health initiatives and regulatory approvals for biologics like Dupixent. The region’s emphasis on chronic disease management and digital dermatology platforms is accelerating market growth.
Key players in the market
Some of the key players in Prurigo Nodularis Treatment Market include AbbVie Inc, Amgen Inc, AstraZeneca, Bayer AG, Dermavant Sciences, Eli Lilly and Company, Galderma, GlaxoSmithKline plc, Incyte Corporation, Johnson & Johnson Services, Inc, Leo Pharma, Merck & Co., Inc, Novartis AG, Pfizer Inc, Regeneron Pharmaceuticals, Inc, Sanofi, Takeda Pharmaceutical Company Limited, Teva Pharmaceutical Industries Ltd, and UCB S.A.
Key Developments:
In June 2025, AbbVie revealed its intention to acquire Capstan Therapeutics to bolster its immunology portfolio, marking another strategic move into next-generation therapies. The deal reflects AbbVie’s ongoing commitment to expanding its presence in autoimmune and inflammatory diseases.
In May 2025, Regeneron agreed to acquire genetic testing company 23andMe following its bankruptcy filing, securing its personal genome service and health-research assets. The deal set to close in Q3 2025 retains all staff and establishes an independent privacy ombudsman to oversee consumer data protections
In April 2025, Regeneron announced a long-term partnership worth over $3 billion with Fujifilm Diosynth Biotechnologies to nearly double its biologics production capacity at Holly Springs, NC, and expand manufacturing footprint nationwide.
Treatment Types Covered:
• Topical Treatments
• Systemic Treatments
• Cryotherapy
• Phototherapy
• Pulsed Dye Laser
• Intralesional Corticosteroid Injections
• Medical Tape/Occlusion
• Other Treatment Types
Route of Administrations Covered:
• Topical
• Oral
• Parenteral
Diagnosis Methods Covered:
• Skin Biopsy
• Blood Tests
• Dermoscopy
• Other Diagnosis Methods
Type of Nodular Prurigos Covered:
• Chronic Nodular Prurigo
• Acute Nodular Prurigo
• Subacute Nodular Prurigo
Distribution Channels Covered:
• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies
Regions Covered:
• North America
o US
o Canada
o Mexico
• Europe
o Germany
o UK
o Italy
o France
o Spain
o Rest of Europe
• Asia Pacific
o Japan
o China
o India
o Australia
o New Zealand
o South Korea
o Rest of Asia Pacific
• South America
o Argentina
o Brazil
o Chile
o Rest of South America
• Middle East & Africa
o Saudi Arabia
o UAE
o Qatar
o South Africa
o Rest of Middle East & Africa
What our report offers:
- Market share assessments for the regional and country-level segments
- Strategic recommendations for the new entrants
- Covers Market data for the years 2024, 2025, 2026, 2028, and 2032
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements
Free Customization Offerings:
All the customers of this report will be entitled to receive one of the following free customization options:
• Company Profiling
o Comprehensive profiling of additional market players (up to 3)
o SWOT Analysis of key players (up to 3)
• Regional Segmentation
o Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
• Competitive Benchmarking
o Benchmarking of key players based on product portfolio, geographical presence, and strategic alliancess
Table of Contents
1 Executive Summary
2 Preface
2.1 Abstract
2.2 Stake Holders
2.3 Research Scope
2.4 Research Methodology
2.4.1 Data Mining
2.4.2 Data Analysis
2.4.3 Data Validation
2.4.4 Research Approach
2.5 Research Sources
2.5.1 Primary Research Sources
2.5.2 Secondary Research Sources
2.5.3 Assumptions
3 Market Trend Analysis
3.1 Introduction
3.2 Drivers
3.3 Restraints
3.4 Opportunities
3.5 Threats
3.6 Emerging Markets
3.7 Impact of Covid-19
4 Porters Five Force Analysis
4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry
5 Global Prurigo Nodularis Treatment Market, By Treatment Type
5.1 Introduction
5.2 Topical Treatments
5.2.1 Corticosteroids
5.2.2 Calcineurin Inhibitors
5.2.3 Capsaicin Cream
5.2.4 Emollients/Moisturizers
5.2.5 Non-prescription Itch Relief
5.3 Systemic Treatments
5.3.1 Antihistamines
5.3.2 Immunosuppressants
5.3.3 Anticonvulsants/Neuropathic Pain Medications
5.3.4 Antidepressants
5.3.5 Biologics
5.3.5.1 IL-4Rα inhibitors
5.3.5.2 IL-31RA antagonists
5.3.5.3 JAK Inhibitors
5.3.5.4 Other Biologics
5.3.6 Opioid Receptor Antagonists
5.3.7 Neurokinin 1 (NK1) Receptor Antagonists
5.3.8 Oral Corticosteroids
5.4 Cryotherapy
5.5 Phototherapy
5.6 Pulsed Dye Laser
5.7 Intralesional Corticosteroid Injections
5.8 Medical Tape/Occlusion
5.9 Other Treatment Types
6 Global Prurigo Nodularis Treatment Market, By Route of Administration
6.1 Introduction
6.2 Topical
6.3 Oral
6.4 Parenteral
7 Global Prurigo Nodularis Treatment Market, By Diagnosis Method
7.1 Introduction
7.2 Skin Biopsy
7.3 Blood Tests
7.4 Dermoscopy
7.5 Other Diagnosis Methods
8 Global Prurigo Nodularis Treatment Market, By Type of Nodular Prurigo
8.1 Introduction
8.2 Chronic Nodular Prurigo
8.3 Acute Nodular Prurigo
8.4 Subacute Nodular Prurigo
9 Global Prurigo Nodularis Treatment Market, By Distribution Channel
9.1 Introduction
9.2 Hospital Pharmacies
9.3 Retail Pharmacies
9.4 Online Pharmacies
10 Global Prurigo Nodularis Treatment Market, By Geography
10.1 Introduction
10.2 North America
10.2.1 US
10.2.2 Canada
10.2.3 Mexico
10.3 Europe
10.3.1 Germany
10.3.2 UK
10.3.3 Italy
10.3.4 France
10.3.5 Spain
10.3.6 Rest of Europe
10.4 Asia Pacific
10.4.1 Japan
10.4.2 China
10.4.3 India
10.4.4 Australia
10.4.5 New Zealand
10.4.6 South Korea
10.4.7 Rest of Asia Pacific
10.5 South America
10.5.1 Argentina
10.5.2 Brazil
10.5.3 Chile
10.5.4 Rest of South America
10.6 Middle East & Africa
10.6.1 Saudi Arabia
10.6.2 UAE
10.6.3 Qatar
10.6.4 South Africa
10.6.5 Rest of Middle East & Africa
11 Key Developments
11.1 Agreements, Partnerships, Collaborations and Joint Ventures
11.2 Acquisitions & Mergers
11.3 New Product Launch
11.4 Expansions
11.5 Other Key Strategies
12 Company Profiling
12.1 AbbVie Inc
12.2 Amgen Inc.
12.3 AstraZeneca
12.4 Bayer AG
12.5 Dermavant Sciences
12.6 Eli Lilly and Company
12.7 Galderma
12.8 GlaxoSmithKline plc
12.9 Incyte Corporation
12.10 Johnson & Johnson Services, Inc.
12.11 Leo Pharma
12.12 Merck & Co., Inc.
12.13 Novartis AG
12.14 Pfizer Inc.
12.15 Regeneron Pharmaceuticals, Inc.
12.16 Sanofi
12.17 Takeda Pharmaceutical Company Limited
12.18 Teva Pharmaceutical Industries Ltd.
12.19 UCB S.A.
List of Tables
1 Global Prurigo Nodularis Treatment Market Outlook, By Region (2024-2032) ($MN)
2 Global Prurigo Nodularis Treatment Market Outlook, By Treatment Type (2024-2032) ($MN)
3 Global Prurigo Nodularis Treatment Market Outlook, By Topical Treatments (2024-2032) ($MN)
4 Global Prurigo Nodularis Treatment Market Outlook, By Corticosteroids (2024-2032) ($MN)
5 Global Prurigo Nodularis Treatment Market Outlook, By Calcineurin Inhibitors (2024-2032) ($MN)
6 Global Prurigo Nodularis Treatment Market Outlook, By Capsaicin Cream (2024-2032) ($MN)
7 Global Prurigo Nodularis Treatment Market Outlook, By Emollients/Moisturizers (2024-2032) ($MN)
8 Global Prurigo Nodularis Treatment Market Outlook, By Non-prescription Itch Relief (2024-2032) ($MN)
9 Global Prurigo Nodularis Treatment Market Outlook, By Systemic Treatments (2024-2032) ($MN)
10 Global Prurigo Nodularis Treatment Market Outlook, By Antihistamines (2024-2032) ($MN)
11 Global Prurigo Nodularis Treatment Market Outlook, By Immunosuppressants (2024-2032) ($MN)
12 Global Prurigo Nodularis Treatment Market Outlook, By Anticonvulsants/Neuropathic Pain Medications (2024-2032) ($MN)
13 Global Prurigo Nodularis Treatment Market Outlook, By Antidepressants (2024-2032) ($MN)
14 Global Prurigo Nodularis Treatment Market Outlook, By Biologics (2024-2032) ($MN)
15 Global Prurigo Nodularis Treatment Market Outlook, By IL-4Rα inhibitors (2024-2032) ($MN)
16 Global Prurigo Nodularis Treatment Market Outlook, By IL-31RA antagonists (2024-2032) ($MN)
17 Global Prurigo Nodularis Treatment Market Outlook, By JAK Inhibitors (2024-2032) ($MN)
18 Global Prurigo Nodularis Treatment Market Outlook, By Other Biologics (2024-2032) ($MN)
19 Global Prurigo Nodularis Treatment Market Outlook, By Opioid Receptor Antagonists (2024-2032) ($MN)
20 Global Prurigo Nodularis Treatment Market Outlook, By Neurokinin 1 (NK1) Receptor Antagonists (2024-2032) ($MN)
21 Global Prurigo Nodularis Treatment Market Outlook, By Oral Corticosteroids (2024-2032) ($MN)
22 Global Prurigo Nodularis Treatment Market Outlook, By Cryotherapy (2024-2032) ($MN)
23 Global Prurigo Nodularis Treatment Market Outlook, By Phototherapy (2024-2032) ($MN)
24 Global Prurigo Nodularis Treatment Market Outlook, By Pulsed Dye Laser (2024-2032) ($MN)
25 Global Prurigo Nodularis Treatment Market Outlook, By Intralesional Corticosteroid Injections (2024-2032) ($MN)
26 Global Prurigo Nodularis Treatment Market Outlook, By Medical Tape/Occlusion (2024-2032) ($MN)
27 Global Prurigo Nodularis Treatment Market Outlook, By Other Treatment Types (2024-2032) ($MN)
28 Global Prurigo Nodularis Treatment Market Outlook, By Route of Administration (2024-2032) ($MN)
29 Global Prurigo Nodularis Treatment Market Outlook, By Topical (2024-2032) ($MN)
30 Global Prurigo Nodularis Treatment Market Outlook, By Oral (2024-2032) ($MN)
31 Global Prurigo Nodularis Treatment Market Outlook, By Parenteral (2024-2032) ($MN)
32 Global Prurigo Nodularis Treatment Market Outlook, By Diagnosis Method (2024-2032) ($MN)
33 Global Prurigo Nodularis Treatment Market Outlook, By Skin Biopsy (2024-2032) ($MN)
34 Global Prurigo Nodularis Treatment Market Outlook, By Blood Tests (2024-2032) ($MN)
35 Global Prurigo Nodularis Treatment Market Outlook, By Dermoscopy (2024-2032) ($MN)
36 Global Prurigo Nodularis Treatment Market Outlook, By Other Diagnosis Methods (2024-2032) ($MN)
37 Global Prurigo Nodularis Treatment Market Outlook, By Type of Nodular Prurigo (2024-2032) ($MN)
38 Global Prurigo Nodularis Treatment Market Outlook, By Chronic Nodular Prurigo (2024-2032) ($MN)
39 Global Prurigo Nodularis Treatment Market Outlook, By Acute Nodular Prurigo (2024-2032) ($MN)
40 Global Prurigo Nodularis Treatment Market Outlook, By Subacute Nodular Prurigo (2024-2032) ($MN)
41 Global Prurigo Nodularis Treatment Market Outlook, By Distribution Channel (2024-2032) ($MN)
42 Global Prurigo Nodularis Treatment Market Outlook, By Hospital Pharmacies (2024-2032) ($MN)
43 Global Prurigo Nodularis Treatment Market Outlook, By Retail Pharmacies (2024-2032) ($MN)
44 Global Prurigo Nodularis Treatment Market Outlook, By Online Pharmacies (2024-2032) ($MN)
Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.
List of Figures
RESEARCH METHODOLOGY
We at ‘Stratistics’ opt for an extensive research approach which involves data mining, data validation, and data analysis. The various research sources include in-house repository, secondary research, competitor’s sources, social media research, client internal data, and primary research.
Our team of analysts prefers the most reliable and authenticated data sources in order to perform the comprehensive literature search. With access to most of the authenticated data bases our team highly considers the best mix of information through various sources to obtain extensive and accurate analysis.
Each report takes an average time of a month and a team of 4 industry analysts. The time may vary depending on the scope and data availability of the desired market report. The various parameters used in the market assessment are standardized in order to enhance the data accuracy.
Data Mining
The data is collected from several authenticated, reliable, paid and unpaid sources and is filtered depending on the scope & objective of the research. Our reports repository acts as an added advantage in this procedure. Data gathering from the raw material suppliers, distributors and the manufacturers is performed on a regular basis, this helps in the comprehensive understanding of the products value chain. Apart from the above mentioned sources the data is also collected from the industry consultants to ensure the objective of the study is in the right direction.
Market trends such as technological advancements, regulatory affairs, market dynamics (Drivers, Restraints, Opportunities and Challenges) are obtained from scientific journals, market related national & international associations and organizations.
Data Analysis
From the data that is collected depending on the scope & objective of the research the data is subjected for the analysis. The critical steps that we follow for the data analysis include:
- Product Lifecycle Analysis
- Competitor analysis
- Risk analysis
- Porters Analysis
- PESTEL Analysis
- SWOT Analysis
The data engineering is performed by the core industry experts considering both the Marketing Mix Modeling and the Demand Forecasting. The marketing mix modeling makes use of multiple-regression techniques to predict the optimal mix of marketing variables. Regression factor is based on a number of variables and how they relate to an outcome such as sales or profits.
Data Validation
The data validation is performed by the exhaustive primary research from the expert interviews. This includes telephonic interviews, focus groups, face to face interviews, and questionnaires to validate our research from all aspects. The industry experts we approach come from the leading firms, involved in the supply chain ranging from the suppliers, distributors to the manufacturers and consumers so as to ensure an unbiased analysis.
We are in touch with more than 15,000 industry experts with the right mix of consultants, CEO's, presidents, vice presidents, managers, experts from both supply side and demand side, executives and so on.
The data validation involves the primary research from the industry experts belonging to:
- Leading Companies
- Suppliers & Distributors
- Manufacturers
- Consumers
- Industry/Strategic Consultants
Apart from the data validation the primary research also helps in performing the fill gap research, i.e. providing solutions for the unmet needs of the research which helps in enhancing the reports quality.
For more details about research methodology, kindly write to us at info@strategymrc.com
Frequently Asked Questions
In case of any queries regarding this report, you can contact the customer service by filing the “Inquiry Before Buy” form available on the right hand side. You may also contact us through email: info@strategymrc.com or phone: +1-301-202-5929
Yes, the samples are available for all the published reports. You can request them by filling the “Request Sample” option available in this page.
Yes, you can request a sample with your specific requirements. All the customized samples will be provided as per the requirement with the real data masked.
All our reports are available in Digital PDF format. In case if you require them in any other formats, such as PPT, Excel etc you can submit a request through “Inquiry Before Buy” form available on the right hand side. You may also contact us through email: info@strategymrc.com or phone: +1-301-202-5929
We offer a free 15% customization with every purchase. This requirement can be fulfilled for both pre and post sale. You may send your customization requirements through email at info@strategymrc.com or call us on +1-301-202-5929.
We have 3 different licensing options available in electronic format.
- Single User Licence: Allows one person, typically the buyer, to have access to the ordered product. The ordered product cannot be distributed to anyone else.
- 2-5 User Licence: Allows the ordered product to be shared among a maximum of 5 people within your organisation.
- Corporate License: Allows the product to be shared among all employees of your organisation regardless of their geographical location.
All our reports are typically be emailed to you as an attachment.
To order any available report you need to register on our website. The payment can be made either through CCAvenue or PayPal payments gateways which accept all international cards.
We extend our support to 6 months post sale. A post sale customization is also provided to cover your unmet needs in the report.
Request Customization
We offer complimentary customization of up to 15% with every purchase. To share your customization requirements, feel free to email us at info@strategymrc.com or call us on +1-301-202-5929. .
Please Note: Customization within the 15% threshold is entirely free of charge. If your request exceeds this limit, we will conduct a feasibility assessment. Following that, a detailed quote and timeline will be provided.
WHY CHOOSE US ?
Assured Quality
Best in class reports with high standard of research integrity
24X7 Research Support
Continuous support to ensure the best customer experience.
Free Customization
Adding more values to your product of interest.
Safe & Secure Access
Providing a secured environment for all online transactions.
Trusted by 600+ Brands
Serving the most reputed brands across the world.
